- Home
- NGVT vs DYN Comparison
NGVT vs DYN Comparison
Compare NGVT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGVT
- DYN
- Stock Information
- Founded
- NGVT 1964
- DYN 1984
- Country
- NGVT United States
- DYN United States
- Employees
- NGVT N/A
- DYN N/A
- Industry
- NGVT Major Chemicals
- DYN Medicinal Chemicals and Botanical Products
- Sector
- NGVT Industrials
- DYN Health Care
- Exchange
- NGVT Nasdaq
- DYN Nasdaq
- Market Cap
- NGVT 2.1B
- DYN 1.9B
- IPO Year
- NGVT N/A
- DYN 2020
- Fundamental
- Price
- NGVT $53.76
- DYN $13.91
- Analyst Decision
- NGVT Buy
- DYN Strong Buy
- Analyst Count
- NGVT 2
- DYN 14
- Target Price
- NGVT $58.00
- DYN $34.93
- AVG Volume (30 Days)
- NGVT 218.6K
- DYN 2.5M
- Earning Date
- NGVT 10-28-2025
- DYN 11-11-2025
- Dividend Yield
- NGVT N/A
- DYN N/A
- EPS Growth
- NGVT N/A
- DYN N/A
- EPS
- NGVT N/A
- DYN N/A
- Revenue
- NGVT $1,324,800,000.00
- DYN N/A
- Revenue This Year
- NGVT N/A
- DYN N/A
- Revenue Next Year
- NGVT $3.95
- DYN N/A
- P/E Ratio
- NGVT N/A
- DYN N/A
- Revenue Growth
- NGVT N/A
- DYN N/A
- 52 Week Low
- NGVT $28.49
- DYN $6.36
- 52 Week High
- NGVT $60.77
- DYN $35.90
- Technical
- Relative Strength Index (RSI)
- NGVT 43.00
- DYN 59.63
- Support Level
- NGVT $53.93
- DYN $12.43
- Resistance Level
- NGVT $57.42
- DYN $13.07
- Average True Range (ATR)
- NGVT 1.54
- DYN 0.78
- MACD
- NGVT -0.40
- DYN -0.01
- Stochastic Oscillator
- NGVT 0.23
- DYN 88.51
About NGVT Ingevity Corporation
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.